
    
      The study was discontinued before the enrollment objective was met. Preliminary review of the
      efficacy dataset revealed that the efficacy dataset was not robust enough to support an
      extensive formal efficacy analysis as described in the SAP. Therefore, only the CRP values
      over time and the percent change in C-reactive protein (CRP) values in the As-Treated
      population were calculated.
    
  